LENSAR financials
$6.90+0.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $58.4M | $53.5M | $42.2M | $35.4M | $34.5M | $26.4M |
| Gross profit | $27.1M | $25.9M | $21.1M | $20.0M | $17.8M | $14.1M |
| Gross margin | 46.4% | 48.3% | 50.1% | 56.4% | 51.8% | 53.4% |
| Operating income | -$24.6M | -$10.7M | -$12.2M | -$20.2M | -$19.7M | -$18.5M |
| Net income | -$34.3M | -$31.4M | -$14.4M | -$19.9M | -$19.6M | -$19.8M |
| Net margin | −58.7% | −58.7% | −34.1% | −56.3% | −56.9% | −75.0% |
| Diluted EPS | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | $-4.28 |
| EBITDA | -$20.1M | -$3.0M | -$8.7M | -$16.3M | -$16.4M | -$15.4M |
| Operating cash flow | -$14.8M | -$2.3M | -$9.7M | -$14.9M | -$9.0M | -$13.8M |
| Free cash flow | -$14.9M | -$2.4M | -$9.9M | -$15.0M | -$9.3M | -$14.2M |
| Diluted shares | 12.0M | 11.5M | 11.0M | 10.2M | 9.4M | 4.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.0M | $16.3M | $20.6M | $14.7M | $31.6M | $40.6M |
| Short-term investments | $5.0M | $6.2M | $3.4M | $0.00 | — | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $71.4M | $66.3M | $69.6M | $55.8M | $66.5M | $79.1M |
| Total liabilities | $83.7M | $47.7M | $22.4M | $13.9M | $11.6M | $11.9M |
| Shareholders' equity | -$26.0M | $4.9M | $33.4M | $42.0M | $54.9M | $67.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology